Tinnitus

The Lancet

Volumn 382, Issue 9904, 2013, Pages 1600-1607

  Baguley, David ^a,b   McFerran, Don ^c   Hall, Deborah ^d  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^c IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^d The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOOXYACETIC ACID; ANTINEOPLASTIC AGENT; BETAHISTINE; BUPIVACAINE; CARBAMAZEPINE; GABAPENTIN; GLUTAMIC ACID; LAMOTRIGINE; MAGNESIUM; MELATONIN; MEMANTINE; METHIONINE; MINERAL; PROCAINE; QUININE; SALICYLIC ACID DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN B GROUP; ZINC;

ACOUSTIC NEURINOMA; ALCOHOL CONSUMPTION; ALTERNATIVE MEDICINE; ANXIETY; APOPTOSIS; ARTHRITIS; AUDITORY NERVOUS SYSTEM; BRAIN DEPTH STIMULATION; BRAIN REGION; CHRONIC PAIN; COCHLEA PROSTHESIS; COGNITIVE THERAPY; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFERENCE PAPER; CONSULTATION; COUNSELING; DEPRESSION; DISEASE ASSOCIATION; DISTRESS SYNDROME; DRUG EXPOSURE; EVIDENCE BASED PRACTICE; FACE PAIN; GENE THERAPY; GENETIC PREDISPOSITION; GOOD CLINICAL PRACTICE; HEAD INJURY; HEALTH INSURANCE; HEARING AID; HEARING IMPAIRMENT; HUMAN; HYPERTENSION; INNER EAR HEARING LOSS; LOUDNESS RECRUITMENT; LOW LEVEL LASER THERAPY; MAGNETIC RESONANCE ANGIOGRAPHY; MENIERE DISEASE; MICROCIRCULATION; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NOISE INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OTOSCLEROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PERCEPTION; PERCEPTION DEAFNESS; PREVALENCE; PRIMARY AUDITORY CORTEX; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; QUALITY OF LIFE; REIMBURSEMENT; RELAXATION TRAINING; RISK FACTOR; SAFETY; SMOKING; STEM CELL TRANSPLANTATION; TEMPOROMANDIBULAR JOINT; TINNITUS; TRANSCRANIAL MAGNETIC STIMULATION; UNITED KINGDOM;

EID: 84887258027     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60142-7     Document Type: Conference Paper

References (105)

1. Stouffer JL, Tyler RS. Characterization of tinnitus by tinnitus patients. J Speech Lang Hear Res 1990; 55: 493-553.
2. Bhimrao SK, Masterson L, Baguley DM. Systematic review of management strategies for middle ear myoclonus. Otolaryngol Head Neck Surg 2012; 146: 698-706.
3. Davis A, El Rafaie A. Epidemiology of tinnitus. In: Tyler RS, ed. Tinnitus handbook. San Diego, CA: Singular, Thomson Learning, 2000: 1-23.
4. Khedr EM, Ahmed MA, Shawky OA, et al. Epidemiological study of chronic tinnitus in Assiut, Egypt. Neuroepidemiology 2010; 35: 45-52.
5. Michikawa T, Nishiwaki Y, Kikuchi Y, et al. Prevalence and factors associated with tinnitus: a community-based study of Japanese elders. J Epidemiol 2010; 20: 271-76.
6. Lasisi AO, Abiona T, Gureje O. Tinnitus in the elderly: profile, correlates, and impact in the Nigerian study of ageing. Otolaryngol Head Neck Surg 2010; 143: 510-15.
7. Baguley DM, McFerran DJ. Tinnitus in childhood. Int J Pediatr Otorhinolaryngol 1999; 49: 99-105.
8. Cianfrone G, Pentangelo D, Cianfrone F, et al. Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide. Eur Rev Med Pharmacol Sci, 2011; 15: 601-36.
9. Nondahl DM, Cruickshanks KJ, Huang G-H, et al. Tinnitus and its risk factors in the Beaver Dam Off spring Study. Int J Audiol 2011; 50: 313-20.
10. Kvestad E, Czajkowski N, Engdahl B, Hoffman HJ, Tambs K. Low heritability of tinnitus: results from the second Nord-Trondelag health study. Arch Otolaryngol Head Neck Surg 2010; 136: 178-82.
11. McKenna L, Hallam RS, Hinchcliffe R. The prevalence of psychological disturbance in neuro-otology outpatients. Clin Otolaryngol Allied Sci 1991; 16: 452-56.
12. Saldanha AD, Hilgenberg PB, Pinto LM, Conti PC. Are temporomandibular disorders and tinnitus associated? Cranio 2012; 30: 166-71.
13. Anari M, Axelsson A, Eliasson A. Magnusson L. Hypersensitivity to sound. Questionnaire data, audiometry and classification. Scand Audiol 1999; 28: 219-30.
14. Coles RRA. Epidemiology of tinnitus: (2) Demographics and clinical features. J Laryngol Otol 1984; 98: (suppl 9) 195-202.
15. Meikle MB, Griest SE. Asymmetry in tinnitus perceptions. Factors that may account for the higher prevalence of left-sided tinnitus. In: Aran JM, Dauman R, eds. Tinnitus 91. Proceedings of the Fourth International Tinnitus Seminar. Amsterdam/New York: Kugler Publications, 1992: 231-37.
16. Nondahl DM, Cruickshanks KJ, Wiley TL, et al. The ten-year incidence of tinnitus among older adults. Int J Audiol 2010; 49: 580-85.
17. Nondahl DM, Cruickshanks KJ, Wiley TL, et al. Prevalence and 5-year incidence of tinnitus among older adults: the epidemiology of hearing loss study. J Am Ac Audiol 2002; 13: 323-31.
18. Eggermont J, Roberts L. The neuroscience of tinnitus. Trends Neurosci 2004; 27: 676-82.
19. House JW, Brackmann DE. Tinnitus: surgical treatment. Ciba Found Symp 1981; 85: 204-16.
20. Noreña AJ. An integrative model of tinnitus based on a central gain controlling neural sensitivity. Neurosci Biobehav Rev 2011; 35: 1089-109.
21. Eggermont JJ. Hearing loss, hyperacusis, or tinnitus - what is modeled in animal research? Hear Res 2013; 295: 140-49.
22. Adjamian P, Sereda M, Hall DA. The mechanisms of tinnitus: perspectives from human functional neuroimaging. Hear Res 2009; 253: 15-31.
23. Noreña AJ, Eggermont JJ. Changes in spontaneous neural activity immediately after an acoustic trauma: implications for neural correlates of tinnitus. Hear Res 2003; 183: 137-53.
24. Seki S, Eggermont JJ. Changes in spontaneous firing rate and neural synchrony in cat primary auditory cortex after localized tone-induced hearing loss. Hear Res 2003; 180: 28-38.
25. Eggermont JJ, Komiya H. Moderate noise trauma in juvenile cats results in profound cortical topographic map changes in adulthood. Hear Res 2000; 142: 89-101.
26. Norena A, Micheyl C, Chéry-Croze S, Collet L. Psychoacoustic characterization of the tinnitus spectrum: implications for the underlying mechanisms of tinnitus. Audiol Neurootol 2002; 7: 358-69.
27. Sereda M, Hall DA, Bosnyak DJ, et al. Re-examining the relationship between audiometric profile and tinnitus pitch. Int J Audiol 2011; 50: 303-12.
28. Flor H, Elbert T, Knecht S, et al. Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation. Nature 1995; 375: 482-84.
29. De Ridder D, Elgoyhen AB, Romo R, Langguth B. Phantom percepts: tinnitus and pain as persisting aversive memory networks. Proc Natt Acad Sci USA 2011; 108: 8075-80.
30. Lanting CP, de Kleine E, van Dijk P. Neural activity underlying tinnitus generation: results from PET and fMRI. Hear Res 2009; 255: 1-13.
31. Dobie RA. A review of randomized clinical trials in tinnitus. Laryngoscope 1999; 109: 1202-11.
32. Landgrebe M, Azevedo A, Baguley D, et al. Methodological aspects of clinical trials in tinnitus: A proposal for an international standard. J Psychosom Res 2012; 73: 112-21.
33. Newman CW, Jacobson GP, Spitzer JB. Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg 1996; 122: 143-48.
34. Hoare DJ, Gander PE, Collins L, Smith S, Hall DA. Management of tinnitus in English NHS audiology departments: an evaluation of current practice. J Eval Clin Pract 2012; 18: 326-34.
35. Meikle MB, Henry JA, Griest SE, et al. The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear Hear 2012; 33: 153-76.
36. Khalfa S, Dubal S, Veuillet E, Perez-Sdiaz F, Jouvent R, Collet L. Psychometric normalisation of a hyperacusis questionnaire. ORL J Otorhinolaryngology Relat Spec 2002; 64: 436-42.
37. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
38. Fowler EP. The illusion of loudness of tinnitus - its etiology and treatment. Laryngoscope 1942; 52: 275-85.
39. Department of Health. Provision of services for adults with tinnitus. A good practice guide. Jan 28, 2009. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicy-AndGuidance/DH-093844 (accessed Oct 28, 2012).
40. Hobson J, Chisholm E, El Refaie A. Sound therapy (masking) in the management of tinnitus in adults. Cochrane Database Syst Rev 2012; 14: CD006371.
41. Noble W. Treatments for tinnitus. Trends Amplif 2008; 12: 236-41.
42. Weise C, Heinecke K, Rief W. Biofeedback-based behavioral treatment for chronic tinnitus: results of a randomized controlled trial. J Consult Clin Psychol 2008; 76: 1046-57.
43. Martinez-Devesa P, Perera R, Theodoulou M, Waddell A. Cognitive behavioural therapy for tinnitus. Cochrane Database Syst Rev 2010; 9: CD005233.
44. Hesser H, Weise C, Westin VZ, Andersson G. A systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy for tinnitus distress. Clin Psychol Rev 2011; 31: 545-53.
45. McFerran DJ, Baguley DM. Is psychology really the best treatment for tinnitus? Clin Otolaryngol 2009; 34: 99-101.
46. Jastreboff PJ, Hazell JWP. A neurophysiological approach to tinnitus: clinical iimplications. Br J Audiol 1993; 27: 7-17.
47. Phillips JS, McFerran D. Tinnitus retraining therapy (TRT) for tinnitus. Cochrane Database Syst Rev 2010; 3: CD007330.
48. Henry JA, Schechter MA, Zaugg TL, et al. Outcomes of clinical trial: tinnitus masking versus tinnitus retraining therapy. J Am Acad Audiol 2006; 17: 104-32.
49. Westin VZ, Schulin M, Hesser H, et al. Acceptance and commitment therapy versus tinnitus retraining therapy in the treatment of tinnitus: a randomised controlled trial. Behav Res Ther 2011; 49: 737-47.
50. Cima RFF, Maes IH, Joore MA, et al. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet 2012; 379: 1951-59.
51. Hoare DJ, Kowalkowski VL, Hall DA. Effects of frequency discrimination training on tinnitus: results from two randomised controlled trials. J Assoc Res Otolaryngol 2012; 13: 543-59.
52. Reavis KM, Rothholtz VS, Tang Q, Carroll JA, Djalilian H, Zeng F-G. Temporary suppression of tinnitus by modulated sounds. J Assoc Res Otolaryngol 2012; 13: 561-71.
53. Sweetow RW, Sabes JH. Effects of acoustic stimuli delivered through hearing aids on tinnitus. J Am Acad Audiol 2010; 21: 461-73.
54. Davis PB, Wilde RA, Steed LG, Hanley PJ. Treatment of tinnitus with a customized acoustic neural stimulus: a controlled clinical study. Ear Nose Throat J 2008; 87: 330-39.
55. Henry JA, Istvan J. An independent review of neuromonics tinnitus treatment controlled clinical trials. Aust N Z J Audiol 2010; 32: 41-55.
56. Seely DR, Quigley SM, Langman AW. Ear candles - efficacy and safety. Laryngoscope 1996; 106: 1226-69.
57. Meng Z, Liu S, Zheng Y, Phillips JS. Repetitive transcranial magnetic stimulation for tinnitus. Cochrane Database Syst Rev 2011; 10: CD007946.
58. Shi Y, Burchiel KJ, Anderson VC, Martin WH. Deep brain stimulation effects in patients with tinnitus. Otolaryngology Head Neck Surg 2009; 141: 285-87.
59. Cheung SW, Larson PS. Tinnitus modulation by deep brain stimulation in locus of caudate neurons (area LC). Neuroscience 2010; 169: 1768-78.
60. Bárány R. Die Beeinflussung des Ohrensausens durch Intravenös Injizierte Lokalanästhetica. Acta Otolaryngol 1935; 23: 201-03.
61. Englesson S, Larsson B, Lindquist NG, Lyttkens L, Stahle J. Accumulation of 14 C-lidocaine in the inner ear. Acta Otolaryngol 1976; 82: 297-300.
62. Weinmeister K. Prolonged suppression of tinnitus after peripheral nerve block using bupivacaine and lidocaine. Reg Anesth Pain Med 2000; 25: 67-68.
63. Baguley D, Jones S, Wilkins I, Axon P, Moffat D. The inhibitory effect of intravenous lidocaine infusion upon tinnitus following translabyrinthine removal of vestibular schwannoma: a double blind placebo control crossover study. Otol Neurotol 2005; 26: 169-76.
64. Kay N. Oral chemotherapy in tinnitus. Br J Audiol 1981; 15: 123-24.
65. Blayney AW, Phillips MS, Guy AM, Colman BH. A sequential double blind cross-over trial of tocainide hydrochloride in tinnitus. Clin Otolaryngol Allied Sci 1985; 10: 97-101.
66. Coles RRA, Thompson AC, O'Donoghue GM. Intra-tympanic injections in the treatment of tinnitus. Clin Otolaryngol Allied Sci 1992; 17: 240-42.
67. Baldo P, Doree C, Lazzarini R, Molin P, McFerran D. Antidepressants for patients with tinnitus. Cochrane Database Syst Rev 2006; 4: CD003853.
68. Johnson RM, Brummett R, Schleuning A. Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg 1993; 119: 842-45.
69. Jalali MM, Kousha A, Naghavi SE, Soleimani R, Banan R. The effects of alprazolam on tinnitus: a cross-over randomized clinical trial. Med Sci Monit 2009; 15: P155-60.
70. Westerberg BD, Roberson JB Jr, Stach BA. A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus. Am J Otol 1996; 17: 896-903.
71. Aazh H, El Refaie A, Humphriss R. Gabapentin for tinnitus: a systematic review. Am J Audiol 2011; 20: 151-58.
72. Bauer CA, Brozoski TJ. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 2006; 116: 675-81.
73. Reed HT, Meltzer J, Crews P, Norris CH, Quine DB, Guth PS. Amino oxyacetic acid as a palliative in tinnitus. Arch Otolaryngol 1985; 111: 803-05.
74. Simpson J, Gilbert A, Weiner G, Davies W. The assessment of lamotrigine, an antiepileptic drug in the treatment of tinnitus. Am J Otol 1999; 20: 627-31.
75. Donaldson I. Tegretol: a double blind trial in tinnitus. J Laryngol Otol 1981; 95: 947-51.
76. Figueiredo R, Langguth B, Mello de Oliveira P, Aparecida de Azevedo A. Tinnitus treatment with memantine. Otolaryngol Head Neck Surg 2008; 138: 492-96.
77. Salembier L, De Ridder D, van de Heyning P. The use of flupirtine in treatment of tinnitus. Acta Otolaryngol Suppl 2006; 126: 93-95.
78. Suckfüll M, Althaus M, Ellers-Lenz B, et al. A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus. BMC Ear Nose Throat Disord 2011; 11: 1.
79. Jayarajan V, Coles R, Treatment of tinnitus with frusemide. J Audiol Med 1993; 2: 114-19.
80. Mora R, Salami A, Barbieri M, et al. The use of sodium enoxaparin in the treatment of tinnitus. Int Tinnitus J 2003; 9: 109-11.
81. Davies E, Knox E, Donaldson I. The usefulness of nimodipine, an L-calcium channel antagonist, in the treatment of tinnitus. Br J Audiol 1994; 28: 125-29.
82. James AL, Burton MJ. Betahistine for Menière's disease or syndrome. Cochrane Database Syst Rev 2001; 1: CD001873.
83. Rosenberg S, Silverstein H, Rowan PT. Effect of melatonin on tinnitus. Laryngoscope 1998; 108: 305-10.
84. Kleinjung T. Low-level laser therapy. In: Møller AR, Langguth B, DeRidder D, Kleinjung T, eds. Textbook of tinnitus. New York: Springer, 2011: 749-52.
85. Wazen JJ, Foyt D, Sisti M. Selective cochlear neurectomy for debilitating tinnitus. Ann Otol Rhinol Laryngol 1997; 106: 568-70.
86. Pulec JL. Cochlear nerve section for intractable tinnitus. Ear Nose Throat J 1995; 74: 468-76.
87. De Ridder D, Møller A. Microvascular compression of the vestibulocochlear nerve. In: Møller AR, Langguth B, DeRidder D, Kleinjung T, eds. Textbook of tinnitus. New York: Springer, 2011: 327-36.
88. Baguley DM, Atlas MD. Cochlear implants and tinnitus. Prog Brain Res 2007; 166: 347-55.
89. Punte AK, Meeus O, van der Heyning P. Cochlear implants and tinnitus. In: Møller AR, Langguth B, DeRidder D, Kleinjung T, eds. Textbook of tinnitus. New York: Springer, 2011: 619-24.
90. Hoare DJ, Hall DA. Clinical guidelines and practice: a commentary on the complexity of tinnitus management. Eval Health Prof 2011; 34: 413-20.
91. Hall DA, Láinez MJA, Newman CW, et al. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA. BMC Health Serv Res 2011; 11: 302.
92. Barton GR, Davis AC, Parving A, Roine R, Sorri M, Stilvén S. Survey of adult hearing aid service expenditure and provision in Denmark, Finland and the UK. Audiol Med 2003; 1: 107-14.
93. Gold SL, Formby C, Gray WC. Celebrating a decade of evaluation and treatment. The University of Maryland Tinnitus and Hyperacusis Center. Am J Audiol 2000; 9: 69-74.
94. Gander PE, Hoare DJ, Collins L, Smith S, Hall DA. Referral pathways for tinnitus management: a comprehensive survey of NHS Audiology Departments in England. BMC Health Serv Res 2011; 11: 162.
95. Alpiner JG, Hansen EM, Kaufman KJ. Transition: rehabilitative audiology into the new millennium. In: Alpiner JG, McCarthy PA, eds. Rehabilitative audiology: children and adults. Baltimore: Lippincott Williams and Wilkins, 2000: 3-24.
96. Gatehouse S. Rehabilitation: identification of needs, priorities and expectations, and the evaluation of benefit. Int J Audiol 2003; 42: S77-S83.
97. Lenarz T, Ernst A. Medical audiology in Germany: before and since reunification. Am J Audiol 1995; 4: 9-11.
98. Hoare DJ, Kowalkowski VL, Hall DA. Systematic review and meta-analyses of randomized controlled trials examining tinnitus management. Laryngoscope 2011; 121: 1255-64.
99. Hall DA, Mohamad N, Firkins L, Fenton M, Stockdale D. Identifying and prioritising unmet research questions for people with tinnitus: the James Lind alliance tinnitus priority setting partnership. Clin Investig (Lond) 2013; 3: 21-28.
100. NHS Evidence-UK Database of Uncertainties about the Effects of Treatments (DUETs). http://www.library.nhs.uk/DUETs/ (accessed Oct 28, 2012).
101. Tyler RS, Noble W, Coelho C. Considerations for the design of clinical trials for tinnitus. Acta Otolaryngol Suppl 2006; 556: 44-49.
102. CONSORT (CONsolidated Standards of Reporting Trials) statement. http://www.consort-statement.org/home/ (accessed Oct 28, 2012).
103. Cotanche DA. Genetic and pharmacological intervention for treatment/prevention of hearing loss. J Commun Disord 2008; 41: 421-43.
104. Campbell K, Claussen A, Meech R, Verhulst S, Fox D, Hughes L. D-methionine (D-met) significantly rescues noise-induced hearing loss: timing studies. Hear Res 2011; 282: 138-44.
105. Le Prell CG, Johnson AC, Lindblad A, et al. Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training. Noise Health 2011; 13: 432-43.